 association bullous pemphigoid malignant disease case control study case control study incidence malignant disease patients bullous pemphigoid BP controls rate malignant disease past concurrent follow-up BP patients controls number malignancies BP group doubtful significance remote attributable treatment rate concurrent BP malignancy weeks slight excess malignancy BP insufficient extensive investigation pursuit cancer Comparison BP patients cancer clinical immunopathological subgroups investigations patients BP malignancy HLA-DR positive immunogenetic predisposition diseases